Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
BMC Cancer
|
June 8, 2010
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study
William Jacot, Marie-Cécile Gerlotto-Borne, Simon Thezenas, et al.
Journal of Pain and Symptom Management
|
April 12, 2011
Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy
Eric Assenat, Simon Thezenas, Nicolas Flori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2025
Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial
Marie Vinches, Chloé Janiszewski, Simon Thezenas, et al.
International Journal of Cancer
|
October 18, 2006
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis
Majida Esslimani-Sahla, Simon Thezenas, Joelle Simony-Lafontaine, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial
David Azria, Olivier Riou, Xavier Rebillard, et al.
Clinical Chemistry and Laboratory Medicine
|
June 22, 2013
Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification
Anna Durigova, Pierre-Jean Lamy, Simon Thezenas, et al.
Breast Cancer Research : BCR
|
December 24, 2011
Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles
William Jacot, Evelyne Lopez-Crapez, Simon Thezenas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 29, 2012
Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients
Christelle Machon, Simon Thezenas, Anne-Marie Dupuy, et al.
Anticancer Research
|
December 31, 2021
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma
Stanislas Quesada, Emmanuelle Samalin, Simon Thezenas, et al.
BMC Cancer
|
July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
BMC Cancer
|
June 8, 2010
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study
William Jacot, Marie-Cécile Gerlotto-Borne, Simon Thezenas, et al.
Journal of Pain and Symptom Management
|
April 12, 2011
Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy
Eric Assenat, Simon Thezenas, Nicolas Flori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2025
Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial
Marie Vinches, Chloé Janiszewski, Simon Thezenas, et al.
International Journal of Cancer
|
October 18, 2006
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis
Majida Esslimani-Sahla, Simon Thezenas, Joelle Simony-Lafontaine, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial
David Azria, Olivier Riou, Xavier Rebillard, et al.
Clinical Chemistry and Laboratory Medicine
|
June 22, 2013
Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification
Anna Durigova, Pierre-Jean Lamy, Simon Thezenas, et al.
Breast Cancer Research : BCR
|
December 24, 2011
Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles
William Jacot, Evelyne Lopez-Crapez, Simon Thezenas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 29, 2012
Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients
Christelle Machon, Simon Thezenas, Anne-Marie Dupuy, et al.
Anticancer Research
|
December 31, 2021
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma
Stanislas Quesada, Emmanuelle Samalin, Simon Thezenas, et al.
BMC Cancer
|
July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Page
of 6